DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Europe Unipolar Depression Epidemiology and Patient Flow Analysis - 2017" report to their offering.
The report provides insights into Unipolar epidemiology, Unipolar diagnosed patients, and Unipolar treatment rate for EU5 pharmaceutical markets.
The study measures key indicators such as prevalence of Unipolar derived from epidemiological analysis, percentage of patients diagnosed with Unipolar, and percentage of patients treated with a therapy.
The study helps executives estimate Unipolar market potential, assess unmet need, develop drug forecasting models, and build population-based health management frameworks. The information presented in this study is used to evaluate market opportunities, effectively identify target patient population, and align marketing decisions.
The report provides estimates and forecasts of Unipolar prevalence, Unipolar diagnosis rate, and Unipolar treatment rate for the period 2016 - 2025.
Key Features of the Report:
- Unipolar Patient Flow
- Unipolar Prevalence
- Unipolar Diagnosed Patients
- Unipolar Treated Patients
Key Topics Covered:
1. Unipolar: Disease Definition
2. Unipolar Patient Flow in Europe
3. Unipolar Patient Flow in Germany
4. Unipolar Patient Flow in France
5. Unipolar Patient Flow in Spain
6. Unipolar Patient Flow in Italy
7. Unipolar Patient Flow in UK
For more information about this report visit http://www.researchandmarkets.com/research/5nvjpb/europe_unipolar